Developing a new class of antibiotics to combat multidrug-resistant bacteria.
2025
Funded
Selected Co-Investor
2021
Founded
Industry
BioTech / Drug Discovery
Stage
Pre-Series A
Developing a new class of antibiotics to combat multidrug-resistant bacteria.
2025
Funded
Selected Co-Investor
2021
Founded
BioTech / Drug Discovery
Pre-Series A
